SARS-CoV-2 and diabetes: A potential therapeutic effect of dipeptidyl peptidase 4 inhibitors in diabetic patients diagnosed with COVID-19

COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 and has become an urgent economic and health challenge. Dipeptidyl peptidase 4 (DPP4), also mentioned as a cluster of differentiation 26 (CD26) is a serine exopeptidase found in two arrangements: a soluble form (sDPP-4) and a plas...

Descripción completa

Detalles Bibliográficos
Autores principales: Kifle, Zemene Demelash, Woldeyohanin, Alem Endeshaw, Demeke, Chilot Abiyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
COVID-19 in Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511553/
https://www.ncbi.nlm.nih.gov/pubmed/34661092
http://dx.doi.org/10.1016/j.metop.2021.100134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511553/
https://www.ncbi.nlm.nih.gov/pubmed/34661092
http://dx.doi.org/10.1016/j.metop.2021.100134

Ejemplares similares